Archived PandoMedia · Undo
Accelerated Medical Diagnostics
PROVIDING PERSONALIZED CHEMOTHERAPY FOR CANCER PATIENTS
Product

PlatinDx, a diagnostic assay for predicting which patients will respond to platinum-based chemotherapy.

Patients are given 1% of the therapeutic dose (a microdose), followed by quantitation of drug-DNA adducts in left-over biopsy tissue using accelerator mass spectrometry. This technology enables detection of drug uptake, drug-DNA damage and other phenotypic markers prior to initiation of chemotherapy.

Founders
  • Nopic
    Cancel
  • Shayna Modarresi
    DealMonkey: High quality deal flow DLA Venture Pipeline - Advisor to start-ups Former Investment Banker (Lazard) Schooling at Berkeley
Referrer
  • Nopic
    Cancel
  • Nopic
    Shayna Modarresi
    Unconfirmed